GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Peterlabs Holdings Bhd (XKLS:0171) » Definitions » Net Margin %

Peterlabs Holdings Bhd (XKLS:0171) Net Margin % : 1.84% (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Peterlabs Holdings Bhd Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Peterlabs Holdings Bhd's Net Income for the three months ended in Sep. 2024 was RM0.8 Mil. Peterlabs Holdings Bhd's Revenue for the three months ended in Sep. 2024 was RM41.6 Mil. Therefore, Peterlabs Holdings Bhd's net margin for the quarter that ended in Sep. 2024 was 1.84%.

The historical rank and industry rank for Peterlabs Holdings Bhd's Net Margin % or its related term are showing as below:

XKLS:0171' s Net Margin % Range Over the Past 10 Years
Min: 1.65   Med: 4.22   Max: 5.51
Current: 1.65


XKLS:0171's Net Margin % is ranked worse than
56.98% of 995 companies
in the Drug Manufacturers industry
Industry Median: 3.96 vs XKLS:0171: 1.65

Peterlabs Holdings Bhd Net Margin % Historical Data

The historical data trend for Peterlabs Holdings Bhd's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peterlabs Holdings Bhd Net Margin % Chart

Peterlabs Holdings Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.44 4.86 2.98 2.23 1.85

Peterlabs Holdings Bhd Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.73 1.59 1.78 1.36 1.84

Competitive Comparison of Peterlabs Holdings Bhd's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peterlabs Holdings Bhd's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's Net Margin % distribution charts can be found below:

* The bar in red indicates where Peterlabs Holdings Bhd's Net Margin % falls into.



Peterlabs Holdings Bhd Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Peterlabs Holdings Bhd's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=3.445/186.208
=1.85 %

Peterlabs Holdings Bhd's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=0.767/41.579
=1.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Peterlabs Holdings Bhd  (XKLS:0171) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Peterlabs Holdings Bhd Net Margin % Related Terms

Thank you for viewing the detailed overview of Peterlabs Holdings Bhd's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Peterlabs Holdings Bhd Business Description

Traded in Other Exchanges
N/A
Address
Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800
Peterlabs Holdings Bhd is a Malaysia-based company engaged in the manufacturing, distribution, and trading of animal health and nutrition products. It also provides solutions like farm management, technical advisory services, raw material analysis, and feed formulation. The operating segments of the group are Manufacturing which relates to the manufacturing of animal health and nutrition products, and Trading which relates to the trading and distribution of animal health and nutrition products. It offers products like animal feed additives, veterinary pharmaceuticals, injectable products, multi-nutrient and supplements, topical dressings, cleansing agents, and other related products. The company operates in Malaysia and internationally and generates key revenue from the Trading segment.

Peterlabs Holdings Bhd Headlines

No Headlines